Novartis: No more R&D investments in India

04/8/2013 | BBC

Novartis will no longer invest in pharmaceutical research and development in India after the Supreme Court refused to grant patent protection on the company's cancer drug Glivec, says Ranjit Shahani, vice chairman and managing director of Novartis India. Other drugmakers probably will do the same, Shahani says.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care